Compass Therapeutics (CMPX) Other Working Capital Changes (2021 - 2026)
Compass Therapeutics (CMPX) posted Other Working Capital Changes of -$38000.0 for Q1 2026, little changed sequentially from -$38000.0 in Q4 2025, and up 84.98% YoY from -$20542.7 in Q1 2025.
Compass Therapeutics (CMPX) Other Working Capital Changes (2021 - 2026) Analysis & Trends
Compass Therapeutics has reported Other Working Capital Changes for 6 years, with the latest figure at -$38000.0 in Q1 2026.
- Quarterly Other Working Capital Changes rose 84.98% year-over-year to -$38000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$154000.0 (up 86.61% YoY) and the FY2025 annual result came in at -$369000.0, up 69.68% from the prior year.
- Other Working Capital Changes was little changed at -$38000.0 in Q1 2026 per CMPX's latest filing, from -$38000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $6.2 million in Q4 2022 and troughed at -$6.3 million in Q2 2025.
- A 5-year average of -$79000.0 and a median of -$312000.0 in 2025 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes surged 101.66% in 2024, then plunged 840.0% in 2025.
- Over 5 years, Other Working Capital Changes stood at -$284000.0 in 2022, then dropped by 9.15% to -$310000.0 in 2023, then slumped by 86.13% to -$577000.0 in 2024, then soared by 93.41% to -$38000.0 in 2025, then changed by 0.0% to -$38000.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$38000.0, -$38000.0, and -$37000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Compass Therapeutics | 405.20 Mn | 405.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -158,000.00 |
| Jun 30, 2026 | -158,000.00 |
| Jun 30, 2026 | -158,000.00 |
| Mar 31, 2026 | -38,000.00 |
| Mar 31, 2026 | -38,000.00 |
| Mar 31, 2026 | -38,000.00 |
| Dec 31, 2025 | -38,000.00 |
| Dec 31, 2025 | -38,000.00 |
| Dec 31, 2025 | -38,000.00 |
| Sep 30, 2025 | -37,000.00 |
| Sep 30, 2025 | -37,000.00 |
| Sep 30, 2025 | -37,000.00 |
| Jun 30, 2025 | -41,000.00 |
| Jun 30, 2025 | -41,000.00 |
| Jun 30, 2025 | -41,000.00 |
| Mar 31, 2025 | -253,000.00 |
| Mar 31, 2025 | -253,000.00 |
| Mar 31, 2025 | -253,000.00 |
| Dec 31, 2024 | -577,000.00 |
| Dec 31, 2024 | -577,000.00 |